COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15606224

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to iRNA, e.g., double-stranded ribonucleic acid (dsRNA), compositions targeting the complement component C5 gene, and methods of using such iRNA, e.g., dsRNA, compositions to inhibit expression of C5 and to treat subjects having a complement component C5-associated disease, e.g., paroxysmal nocturnal hemoglobinuria.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALNYLAM PHARMACEUTICALS INC675 WEST KENDALL STREET HENRI A TERMEER SQUARE CAMBRIDGE MA 02142-1110

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bettencourt, Brian Groton, US 134 658
Borodovsky, Anna Melrose, US 54 422
Butler, James Lynnfield, US 112 2166
Charisse, Klaus Acton, US 73 449
Fitzgerald, Kevin Brookline, US 209 2389
Foster, Donald Attleboro, US 35 131
Kuchimanchi, Satyanarayana Acton, US 61 396
Maier, Martin Belmont, US 260 4382
Manoharan, Muthiah Weston, US 491 18658
Rajeev, Kallanthottathil G Wayland, US 260 8660

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation